Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

‘Wildcard’ Patents: Why A REVAMP-ed Proposal Might Work In 2017

Nov 17 2016

• By Michael McCaughan and Laura Helbling

Red and blue arrow elevators with businessmen going up and down.

Related Content

Doubling Down On Antibiotic Incentives: Congress, Obama Administration Drafting Proposals

Nov 12 2014

Value-Based Reimbursement For Antibiotics Gets Skeptical Reception

Nov 16 2016

Antibiotic Development: ‘Wildcard Exclusivity’ Proposal Returns

Nov 16 2016

Additional Topics

United States Legislation Elections Policy Intellectual Property BioPharmaceutical

More from Legislation

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window